MTHFR gene polymorphisms and bladder cancer susceptibility: A meta-analysis including race, smoking status and tumour stage

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2227-2232

  Kouidhi, Soumaya ^a   Rouissi, Kamel ^a   Khedhiri, Sami ^b   Ouerhani, Slah ^c   Cherif, Mohamed ^d   Benammar Elgaaied, Amel ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^c INSTITUT PASTEUR   (France)

^d CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Bladder cancer; Methylenetetrahydrofolate reductase; Polymorphism; Prognosis; Susceptibility

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; CASE CONTROL STUDY; ENZYMOLOGY; ETHNOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS; MIDDLE AGED; PATHOLOGY; RACE; RISK FACTOR; SMOKING;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84865840831     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cai DW, Liu XF, Bu RG, Chen XN, et al (2009). Genetic polymorphisms of MTHFR and aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese population. J Int Med Res, 37, 1882-9.
2. Chung CJ, Pu YS, Su CT, et al (2010). Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma. Cancer Causes Control, 21, 1605-13.
3. Cohen SM, Shirai T, Steineck G (2000). Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl, 2, 105-15.
4. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
5. Dong X, Wu J, Liang P, et al (2010). Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis. Arch Med Res, 41, 125-33.
6. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple graphical test. BMJ, 315, 629-34.
7. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
8. García-Closas R, García-Closas M, Kogevinas M, et al (2007). Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer, 43, 1731-40.
9. Guéant JL, Chabi NW, Guéant-Rodriguez RM, et al (2007). Environmental influence on the worldwide prevalence of a 776C->G variant in the transcobalamin gene (TCN2). J Med Genet, 44, 363-7.
10. Goyette P, Pai A, Milos R, et al (1998). Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome, 9, 652-6.
11. Helfenstein T, Fonseca FA, Relvas WG, et al (2005). Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects. Clin Chim Acta, 355, 165-72.
12. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
13. Hoover R, Cole P (1971). Population trends in cigarette smoking and bladder cancer. Am J Epidemiol, 94, 409-18.
14. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin 2011, 61, 69-90.
15. Jemal A, Siegel R, Xu J, Ward E. (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300.
16. Karagas MR, Park S, Nelson HH, et al (2005). Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. Int J Hyg Environ Health, 208, 321-7.
17. Khedhiri S, Stambouli N, Ouerhani S, et al (2010). The impact of smoking and polymorphism of xenobiotic metabolizing enzymes on the stage of bladder tumors: A generalized ordered logistic regression analysis, J of Cancer Research and Clin Oncology, 136(7), 1111-6.
18. Kimura F, Florl AR, Steinhoff C, et al (2001). Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder. Mutat Res, 458, 49-54
19. Lin J, Spitz MR, Wang Y, et al (2004). Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis, 25, 1639-47.
20. Lwin H, Yokoyama T, Date C, et al (2002). Are the associations between life-style related factors and plasma total homocysteine concentration different according to polymorphism of 5,10-methylenetetrahydrofolate reductase gene (C677T MTHFR)? A cross-sectional study in Japanese rural population. J Epidemiol, 12, 126-35.
21. Mannino DM, Mulinare J, Ford ES, et al (2003). Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res, 5, 357-62.
22. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
23. Moore LE, Malats N, Rothman N, et al (2007). Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer, 120, 2452-8.
24. Moore LE, Wiencke JK, Bates MN, et al (2004). Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett, 211, 199-207.
25. Ouerhani S, Rouissi K, Marrakchi R, et al (2009). Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population. Cancer Detect Prev, 32, 395-402.
26. Ouerhani S, Oliveira E, Marrakchi R, et al (2007). Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Cancer Genet Cytogenet, 176, 48-53.
27. Rouissi K, Stambouli N, Marrakchi R, et al (2011). Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors. Bull Cancer, [Epub ahead of print].
28. Rouissi K, Ouerhani S, Oliveira E et al (2009). Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genet Cytogenet, 195, 43-53.
29. Safarinejad MR, Shafiei N, Safarinejad S (2010). Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men. Med Oncol, (in press).
30. Sanyal S, Ryk C, De Verdier PJ et al (2007). Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms. Scand J Urol Nephrol, 41, 182-90.
31. Sanyal S, Festa F, Sakano S et al (2004). Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis, 25, 729-34.
32. Saw SM, Yuan JM, Ong CN et al (2001). Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am J Clin Nutr, 73, 232-9.
33. Sun J, Xu Y, Zhu Y, Lu H (2004). Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract, 64,185-90.
34. Tungtrongchitr R, Pongpaew P, Soonthornruengyot M, et al (2003). Relationship of tobacco smoking with serum vitamin B12, folic acid and haematological indices in healthy adults. Public Health Nutr, 6, 675-81.
35. Van der Put NM, Gabreëls F, Stevens EM et al (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet, 62, 1044-51.
36. Wang M, Zhu H, Fu G et al (2009). Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control study with meta-analysis. Clin Exp Med, 9, 9-19.
37. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab, 64, 169-72.
38. Wynder EL, Goldsmith R (1977). The epidemiology of bladder cancer: a second look. Cancer, 40, 1246-68.
39. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA (2000). The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer, 89, 630-9.